VirtuOx competitors

Massi Joe E. Kiani (born September 16, 1964) is an Iranian-born American entrepreneur who founded medical technology company Masimo in 1989.

Michael “Mick” Farrell was appointed ResMed’s CEO and has served as a director since March 2013. He joined the company in 2000, serving as president of the Americas region from 2011 to 2013, senior vice president of the global sleep apnea business unit from 2007 to 2011, and various senior roles in marketing and business development. Before joining ResMed, Mick worked in management consulting, biotechnology, chemicals and metals manufacturing at companies including Arthur D. Little, Sanofi Genzyme, DowDuPont, and BHP Billiton. Mick serves on the board of directors of ResMed, the Advanced Medical Technology Association (AdvaMed) and Zimmer Biomet (NYSE: ZBH), a multibillion dollar public company that provides implantable musculoskeletal medical devices for patients globally. He is also a member of two committees at Zimmer Biomet: Nominating and Governance as well as Compensation and Management Development. He also volunteers as a trustee for non-profit organizations: UC San Diego Foundation, Rady Children’s Hospital, the La Jolla Playhouse, and Father Joe’s Villages in San Diego, California. Mick holds a bachelor of engineering with first-class honors from the University of New South Wales, a Master of Science in chemical engineering from the Massachusetts Institute of Technology, and a Master of Business Administration from the MIT Sloan School of Management.

As Chief Executive Officer, Daniel Baker is leading HealthDrive’s dedicated team in industry innovation and expansion. Baker was elected CEO in September 2017 after serving as HealthDrive’s Chief Operating Officer for four years. Prior to joining HealthDrive, Dan worked for Omnicare, a provider of pharmacy services to the long-term care industry, for ten years. In his role as Regional Vice President, he managed ten pharmacy operations with an annual revenue of $550 million and led the turnaround of challenged operating units. Mr. Baker has a B.S. in Chemistry and a Minor in Economics from Georgetown University.

Doug Lucente is Chief Executive Officer of PROMEDICAL, a national healthcare revenue cycle management company. Known for innovation, quality, and exceptional client service PROMEDICAL provides third party liability solutions including workers' compensation and motor vehicle accident billing and a proprietary document imaging service. Mr. Lucente has led the company since 1996, creating its vision, strategic direction and leadership team. He has transformed the company into a national, client-focused, technology driven, healthcare revenue cycle partner. Mr. Lucente is a member of the Massachusetts Bar Association, American Bar Association - Health Law Division, HFMA and has earned a JD (Suffolk University) and BA (American University). Committed to social causes, Mr. Lucente is actively involved in non-profit work in the local community. Specialties: Leadership, Healthcare, Third-Party-Liability, Profit and Loss Management, Start-ups, Business Strategy, Information Technology, Client Service, Marketing, Sales, CEO, President, General Manager, Non-Profits

John T. Spitznagel is a Chief Executive Officer at NovaSom Inc and is based in Auburn, New York.

Carroll is a seasoned executive with over 30 years focused on diagnostics. He served as president of a large in vitro diagnostics medical device/assay manufacturing company, DiaSorin, and has held several executive level positions with other diagnostic companies, as well as in hospital services, managed care providers, and home health companies. Carroll brings a deep level of international business development, licensing and contracting, and distribution channel development experience to the company.